48 related articles for article (PubMed ID: 36074219)
1. Visible photorelease of liquid biopsy markers following microfluidic affinity-enrichment.
Pahattuge TN; Jackson JM; Digamber R; Wijerathne H; Brown V; Witek MA; Perera C; Givens RS; Peterson BR; Soper SA
Chem Commun (Camb); 2020 Apr; 56(29):4098-4101. PubMed ID: 32163053
[TBL] [Abstract][Full Text] [Related]
2. Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients.
Pereira-Veiga T; Bravo S; Gómez-Tato A; Yáñez-Gómez C; Abuín C; Varela V; Cueva J; Palacios P; Dávila-Ibáñez AB; Piñeiro R; Vilar A; Chantada-Vázquez MDP; López-López R; Costa C
Mol Cell Proteomics; 2022 Dec; 21(12):100435. PubMed ID: 36519745
[TBL] [Abstract][Full Text] [Related]
3. Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer.
Welsch E; Schuster E; Krainer M; Marhold M; Bartsch R; Fischer MB; Hermann M; Hastermann G; Uher H; Sliutz G; Anker B; Zeillinger R; Obermayr E
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831613
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer circulating tumor cells with mesenchymal features-an unreachable target?
Topa J; Grešner P; Żaczek AJ; Markiewicz A
Cell Mol Life Sci; 2022 Jan; 79(2):81. PubMed ID: 35048186
[TBL] [Abstract][Full Text] [Related]
5. Comparison of microfluidic platforms for the enrichment of circulating tumor cells in breast cancer patients.
Sajdik C; Schuster E; Holzer B; Krainer M; Deutschmann C; Peter S; Marhold M; Zeillinger R; Obermayr E
Breast Cancer Res Treat; 2022 Nov; 196(1):75-85. PubMed ID: 36074219
[TBL] [Abstract][Full Text] [Related]
6. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
[TBL] [Abstract][Full Text] [Related]
7. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
[TBL] [Abstract][Full Text] [Related]
9. [Recent advances in isolation and detection of circulating tumor cells with a microfluidic system].
Cao R; Zhang M; Yu H; Qin J
Se Pu; 2022 Mar; 40(3):213-223. PubMed ID: 35243831
[TBL] [Abstract][Full Text] [Related]
10. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
[TBL] [Abstract][Full Text] [Related]
11. Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
Ring A; Campo D; Porras TB; Kaur P; Forte VA; Tripathy D; Lu J; Kang I; Press MF; Jeong YJ; Snow A; Zhu Y; Zada G; Wagle N; Lang JE
Ann Surg Oncol; 2022 May; 29(5):2882-2894. PubMed ID: 35000083
[TBL] [Abstract][Full Text] [Related]
12. RNA-Based CTC Analysis Provides Prognostic Information in Metastatic Breast Cancer.
Strati A; Nikolaou M; Georgoulias V; Lianidou ES
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33799422
[TBL] [Abstract][Full Text] [Related]
13. Cut-Off Analysis of CTC Change under Systemic Therapy for Defining Early Therapy Response in Metastatic Breast Cancer.
Deutsch TM; Stefanovic S; Feisst M; Fischer C; Riedel F; Fremd C; Domschke C; Pantel K; Hartkopf AD; Sutterlin M; Brucker SY; Schneeweiss A; Wallwiener M
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32344685
[TBL] [Abstract][Full Text] [Related]
14. Gene Expression Alterations during Development of Castration-Resistant Prostate Cancer Are Detected in Circulating Tumor Cells.
Josefsson A; Larsson K; Freyhult E; Damber JE; Welén K
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877738
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
